Good morning :)
Place Order
Add to Watchlist

Bliss GVS Pharma Ltd

BLISSGVS Share Price

156.250.04% (-0.06)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹1,648 cr, stock is ranked 1,239

Stock is 4.08x as volatile as Nifty

BLISSGVS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹1,648 cr, stock is ranked 1,239

Stock is 4.08x as volatile as Nifty

BLISSGVS Performance & Key Metrics

BLISSGVS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
19.551.640.32%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.156.590.81%

BLISSGVS Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

BLISSGVS Company Profile

Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.

BLISSGVS Similar Stocks (Peers)

Compare with peers Compare with peers 

BLISSGVS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.80
36.80
1Y Return
7.60%
7.60%
Buy Reco %
87.88
87.88
PE Ratio
23.18
23.18
1Y Return
2.20%
2.20%
Buy Reco %
73.33
73.33
PE Ratio
59.65
59.65
1Y Return
17.34%
17.34%
Buy Reco %
70.83
70.83
PE Ratio
19.24
19.24
1Y Return
0.89%
0.89%
Buy Reco %
55.17
55.17
PE Ratio
22.26
22.26
1Y Return
11.97%
11.97%
Buy Reco %
44.44
44.44
Compare with Peers

BLISSGVS Forecast

BLISSGVS Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

BLISSGVS

BLISSGVS

Income

Balance Sheet

Cash Flow

BLISSGVS Income Statement

BLISSGVS Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 3.04%, vs industry avg of 10.14%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.29% to 0.2%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -2.82%, vs industry avg of 20.01%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue810.94841.18936.20728.50597.43778.94769.38798.98846.22846.22
Raw Materialssubtract368.69391.70618.79435.67341.59420.18374.38390.46683.04683.04
Power & Fuel Costsubtract5.585.494.765.888.148.257.1310.43
Employee Costsubtract61.3569.2342.3253.6968.0976.1586.1795.58
Selling & Administrative Expensessubtract117.9087.5749.9645.3044.9180.6580.4585.89
Operating & Other expensessubtract42.1997.7225.1038.837.82117.4886.1366.45
Depreciation/Amortizationsubtract20.1421.388.9412.5917.2317.3318.6726.3829.4229.42
Interest & Other Itemssubtract19.6922.804.417.575.514.7410.366.918.128.12
Taxes & Other Itemssubtract93.3686.5158.1931.7135.6339.1335.2241.4141.3541.33
EPS7.955.7012.009.436.641.456.827.238.028.05
DPS0.601.001.000.500.500.500.500.500.500.50
Payout ratio0.080.180.080.050.080.340.070.070.060.06

BLISSGVS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF

Investor Presentation

Aug 21PDF
FY 2019FY 2019

Annual report

PDF

Investor Presentation

May 21PDF
Feb 1PDF
Nov 3PDF
Aug 9PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

BLISSGVS Stock Peers

BLISSGVS Past Performance & Peer Comparison

BLISSGVS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bliss GVS Pharma Ltd19.561.640.32%
Sun Pharmaceutical Industries Ltd36.805.990.95%
Cipla Ltd23.183.911.06%
Torrent Pharmaceuticals Ltd59.6516.630.95%

BLISSGVS Stock Price Comparison

Compare BLISSGVS with any stock or ETF
Compare BLISSGVS with any stock or ETF
BLISSGVS
Loading...

BLISSGVS Holdings

BLISSGVS Shareholdings

BLISSGVS Promoter Holdings Trend

BLISSGVS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

BLISSGVS Institutional Holdings Trend

BLISSGVS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

BLISSGVS Shareholding Pattern

BLISSGVS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding35.29%0.00%6.55%13.18%44.98%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

BLISSGVS Shareholding History

BLISSGVS Shareholding History

Dec '23MarJunSepDec '24Mar15.35%14.73%13.25%12.13%13.51%13.18%

Mutual Funds Invested in BLISSGVS

Mutual Funds Invested in BLISSGVS

No mutual funds holding trends are available

Top 1 Mutual Funds holding Bliss GVS Pharma Ltd


Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
0.0007%0.07%-0.01%89/109 (-11)

Compare 3-month MF holding change on Screener

BLISSGVS Insider Trades & Bulk Stock Deals

BLISSGVS Insider Trades & Bulk Stock Deals

Loading...

smallcases containing BLISSGVS stock

smallcases containing BLISSGVS stock

Looks like this stock is not in any smallcase yet.

BLISSGVS Events

BLISSGVS Events

BLISSGVS Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

BLISSGVS has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.32%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.18 every year

Dividends

Corp. Actions

Announcements

Legal Orders

BLISSGVS Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

BLISSGVS has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.32%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.18 every year

BLISSGVS Upcoming Dividends

BLISSGVS Upcoming Dividends

No upcoming dividends are available

BLISSGVS Past Dividends

BLISSGVS Past Dividends

Cash Dividend

Ex DateEx DateJul 18, 2024

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 18, 2024

Cash Dividend

Ex DateEx DateJul 12, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 12, 2023

Cash Dividend

Ex DateEx DateJun 20, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jun 20, 2022

Cash Dividend

Ex DateEx DateSep 13, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 13, 2021

Cash Dividend

Ex DateEx DateSep 17, 2020

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 17, 2020

BLISSGVS Stock News & Opinions

BLISSGVS Stock News & Opinions

Spotlight
Bliss GVS Pharma Ltd leads gainers in 'B' group

Northern ARC Capital Ltd, Apollo Micro Systems Ltd, IRM Energy Ltd and Malu Paper Mills Ltd are among the other gainers in the BSE's 'B' group today, 23 June 2025.Bliss GVS Pharma Ltd soared 9.58% to Rs 151.5 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.18 lakh shares were traded on the counter so far as against the average daily volumes of 68368 shares in the past one month. Northern ARC Capital Ltd spiked 9.58% to Rs 228.15. The stock was the second biggest gainer in 'B' group. On the BSE, 14.3 lakh shares were traded on the counter so far as against the average daily volumes of 5.2 lakh shares in the past one month. Apollo Micro Systems Ltd surged 9.00% to Rs 212.55. The stock was the third biggest gainer in 'B' group. On the BSE, 16.72 lakh shares were traded on the counter so far as against the average daily volumes of 11.4 lakh shares in the past one month. IRM Energy Ltd spurt 8.85% to Rs 311.9. The stock was the fourth biggest gainer in 'B' group. On the BSE, 19887 shares were traded on the counter so far as against the average daily volumes of 5288 shares in the past one month. Malu Paper Mills Ltd gained 8.44% to Rs 41.65. The stock was the fifth biggest gainer in 'B' group. On the BSE, 4676 shares were traded on the counter so far as against the average daily volumes of 3845 shares in the past one month. Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Bliss GVS Pharma allots 75,250 equity shares under ESOP

Bliss GVS Pharma has allotted 75,250 equity shares under ESOP on 06 June 2025. Consequently, the paid up equity share capital has increased to 10,54,45,522 equity shares of Re. 1/- each aggregating Rs. 10,54,45,522 /. Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Bliss GVS Pharma schedules AGM

Bliss GVS Pharma announced that the 40th Annual General Meeting(AGM) of the company will be held on 31 July 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Bliss GVS Pharma recommends final dividend

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 12 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Bliss GVS Pharma reports consolidated net profit of Rs 15.54 crore in the March 2025 quarter

Net profit of Bliss GVS Pharma reported to Rs 15.54 crore in the quarter ended March 2025 as against net loss of Rs 9.15 crore during the previous quarter ended March 2024. Sales declined 0.07% to Rs 197.99 crore in the quarter ended March 2025 as against Rs 198.13 crore during the previous quarter ended March 2024. For the full year,net profit rose 11.73% to Rs 84.30 crore in the year ended March 2025 as against Rs 75.45 crore during the previous year ended March 2024. Sales rose 5.13% to Rs 809.73 crore in the year ended March 2025 as against Rs 770.24 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales197.99198.13 0 809.73770.24 5 OPM %10.6514.31 -15.6519.55 - PBDT31.4832.10 -2 155.06172.45 -10 PBT23.4425.25 -7 125.64146.07 -14 NP15.54-9.15 LP 84.3075.45 12 Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Bliss GVS Pharma reports standalone net profit of Rs 11.45 crore in the March 2025 quarter

Net profit of Bliss GVS Pharma reported to Rs 11.45 crore in the quarter ended March 2025 as against net loss of Rs 11.46 crore during the previous quarter ended March 2024. Sales declined 4.77% to Rs 156.00 crore in the quarter ended March 2025 as against Rs 163.82 crore during the previous quarter ended March 2024. For the full year,net profit rose 36.20% to Rs 68.97 crore in the year ended March 2025 as against Rs 50.64 crore during the previous year ended March 2024. Sales rose 10.20% to Rs 667.20 crore in the year ended March 2025 as against Rs 605.46 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales156.00163.82 -5 667.20605.46 10 OPM %8.8015.36 -13.7317.70 - PBDT21.7932.09 -32 121.22134.86 -10 PBT14.3625.86 -44 94.17111.34 -15 NP11.45-11.46 LP 68.9750.64 36 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Bliss GVS Pharma to announce Quarterly Result

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 12 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Bliss GVS Pharma invokes arbitration proceedings against Pan Pharmaceuticals, Kenya

Bliss GVS Pharma had invoked arbitration proceedings against Pan Pharmaceuticals (Nairobi, Kenya) for recovery of its outstanding dues by way of filing a petition seeking appointment of an arbitrator before the Supreme Court of India. The expected recovery arising from the aforementioned arbitration proceedings is estimated at USD 1.69 million. Furthermore, the Company has proactively made appropriate provisions in its books of accounts for the amount recoverable from Pan Pharmaceuticals, thereby ensuring minimal or no adverse financial impact. The quantum of claim will depend upon the outcome of the arbitrating authority.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Bliss GVS Pharma consolidated net profit declines 13.80% in the December 2024 quarter

Net profit of Bliss GVS Pharma declined 13.80% to Rs 23.80 crore in the quarter ended December 2024 as against Rs 27.61 crore during the previous quarter ended December 2023. Sales rose 4.83% to Rs 210.42 crore in the quarter ended December 2024 as against Rs 200.72 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales210.42200.72 5 OPM %14.1521.77 - PBDT43.9747.00 -6 PBT36.4240.04 -9 NP23.8027.61 -14 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Bliss GVS Pharma schedules board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Bliss GVS Pharma Ltd (BLISSGVS) today?

    The share price of BLISSGVS as on 4th July 2025 is ₹156.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Bliss GVS Pharma Ltd (BLISSGVS) share?

    The past returns of Bliss GVS Pharma Ltd (BLISSGVS) share are
    • Past 1 week: 3.94%
    • Past 1 month: 16.27%
    • Past 3 months: 29.78%
    • Past 6 months: -6.34%
    • Past 1 year: 37.73%
    • Past 3 years: 115.37%
    • Past 5 years: 63.36%

  3. What are the peers or stocks similar to Bliss GVS Pharma Ltd (BLISSGVS)?
  4. What is the dividend yield % of Bliss GVS Pharma Ltd (BLISSGVS) share?

    The current dividend yield of Bliss GVS Pharma Ltd (BLISSGVS) is 0.32.

  5. What is the market cap of Bliss GVS Pharma Ltd (BLISSGVS) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bliss GVS Pharma Ltd (BLISSGVS) is ₹1648.40 Cr as of 4th July 2025.

  6. What is the 52 week high and low of Bliss GVS Pharma Ltd (BLISSGVS) share?

    The 52-week high of Bliss GVS Pharma Ltd (BLISSGVS) is ₹185.50 and the 52-week low is ₹103.01.

  7. What is the PE and PB ratio of Bliss GVS Pharma Ltd (BLISSGVS) stock?

    The P/E (price-to-earnings) ratio of Bliss GVS Pharma Ltd (BLISSGVS) is 19.56. The P/B (price-to-book) ratio is 1.64.

  8. Which sector does Bliss GVS Pharma Ltd (BLISSGVS) belong to?

    Bliss GVS Pharma Ltd (BLISSGVS) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Bliss GVS Pharma Ltd (BLISSGVS) shares?

    You can directly buy Bliss GVS Pharma Ltd (BLISSGVS) shares on Tickertape. Simply sign up, connect your demat account and place your order.